(Q34636518)
Statements
Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC (English)
Selda Samakoglu
Dhanvanthri S Deevi
Huiling Li
Su Wang
Mary Murphy
Channa Bao
Rajiv Bassi
Marie Prewett